Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Sickle Cell Disease
Conditions : Sickle Cell Disease; Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0) Interventions : Biological: autologous bone marrow derived CD34+ HSPCs electroporated with BCL11A enhancer targeting…
Read the full article2d agoen
Comments
Sign in to join the conversation.
No comments yet. Be the first.